Poland· PL-100137084
Angeliq
A norethisteron und estrogen product containing estradiolum + drospirenonum, registered in Poland by Bayer AG. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Norethisteron und estrogen is registered in 11 of 19 countries.
Countries holding a registration under ATC G03FA01 (norethisteron und estrogen), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Norethisteron und estrogen · ATC G03FA01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Estradiolum + Drospirenonum
- Manufacturer
- Bayer AG
- Country
- Poland (PL)
- ATC code
- G03FA01
- ATC class
- Norethisteron und Estrogen
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
1 priced- gtin0590999022107328 szt.PLN 43.55
- gtin05909990221080
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
11 interactions on record for norethisteron und estrogen.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Norethisteron und estrogen · interactions on record
11 records
11 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Norethisteron und estrogen in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandAllureneBayer Schering Pharma Oy
- SwitzerlandAngeliq
- GermanyAngeliqBayer Vital Gmbh
- SpainANGELIQ 1 mg/2 mg COMPRIMIDOS RECUBIERTOS CON PELICULABayer Hispania S.L.
- United KingdomAngeliq 1mg/2mg tabletsBayer Plc
- United StatesAngeliqBayer HealthCare Pharmaceuticals Inc.
- ItalyANGELIQBAYER S.P.A.
- NetherlandsAngeliq, 1 mg/2 mg filmomhulde tablettenBayer B.V.
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Belgium · Angeliq, Klimedix
- Czechia · Angeliq, Paosonelle
- Germany · Angeliq, Klimedix
- Estonia · Angeliq
- Spain · Angeliq
- Finland · Angeliq
- Croatia · Angeliq
- Ireland · Angeliq
- Italy · Angeliq, Paosonelle
- Lithuania · Angeliq
- Luxembourg · Angeliq
- Latvia · Angeliq, Klimedix
- Malta · Angeliq
- Netherlands · Angeliq, Paosonelle
- Portugal · Angeliq, Klimedix
- Slovenia · Angeliq
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/451a4868-37f3-4425-9aff-a75afdb2743a GET /v1/drugs/451a4868-37f3-4425-9aff-a75afdb2743a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "1 mg + 2 mg",
"packaging": "05909990221073 ¦ Rp ¦ 27077\n28 tabl.\n05909990221080 ¦ Rp ¦ 27078\n84 tabl.",
"substance": "Estradiolum 1 mg + Drospirenonum 2 mg",
"common_name": "Estradiolum + Drospirenonum",
"pl_product_id": "100137084",
"pozwolenie_nr": "11478",
"auth_procedure": "MRP",
"authorisation_validity": "Bezterminowe"
}See everything about norethisteron und estrogen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.